2023-11-12 20:18:36
Title: Breakthrough in mRNA Vaccinations: Potential Use in Fight Against Cancer
As of: November 12, 2023, 7:18 p.m
By: Karolin Schäfer
The corona pandemic has brought about a significant breakthrough in mRNA vaccinations, paving the way for potential use in the fight against cancer in the future.
According to the Center for Cancer Registry Data, around 4.65 million people in Germany are living with cancer. Despite ongoing research into new treatment methods, more than 230,000 people succumb to the disease each year. However, there is hope on the horizon as biotech company Curevac is aiming to bring a cancer vaccination to the market by 2028.
Curevac’s new CEO, Alexander Zehnder, stated, “Cancer will no longer be a death sentence.” The company is focusing on mRNA-based drugs and is making significant progress in its fight against cancer. Zehnder attributed the current progress to the breakthrough for mRNA vaccinations brought about by the corona pandemic.
The potential cancer vaccination could be administered to high-risk patients, potentially containing the tumor and even stopping its growth, according to Zehnder. The aim is for cancer to become a chronic disease that individuals can live with for decades. Biontech, another pharmaceutical company, has also reported breakthroughs in cancer vaccination research, with a potential breakthrough expected before 2030.
One of the advantages of mRNA vaccinations in cancer treatment is that they target only cancer cells, stimulating the immune system to do so. This differs from conventional treatments such as radiation or chemotherapy, which can also affect the entire body.
With the potential for mRNA vaccinations in the fight against cancer, there is newfound hope for improving the survival rates of cancer patients. Researchers have also identified an area of an antigen that can cause tumor cells to die, offering promising prospects for the future of cancer treatment.]
#Curevac #boss #expects #vaccination